Fever-induced QTc prolongation and ventricular arrhythmias in individuals with type 2 congenital long QT syndrome

Journal of Clinical Investigation

Volumn 118, Issue 7, 2008, Pages 2552-2561

  Amin, Ahmad S ^a,b   Herfst, Lucas J ^c,d   Delisle, Brian P ^b   Klemens, Christine A ^b   Rook, Martin B ^c   Bezzina, Connie R ^a   Underkofler, Heather A S ^b   Holzem, Katherine M ^b   Ruijter, Jan M ^a   Tan, Hanno L ^a   January, Craig T ^b,f   Wilde, Arthur A M ^a,e  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d HUMBOLDT UNIVERSITY   (Germany)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; CELL STRAIN HEK293; CHEMICAL ANALYSIS; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; FEMALE; FEVER; GENE EXPRESSION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH TEMPERATURE; HUMAN; HUMAN CELL; LONG QT SYNDROME; MALE; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; QT PROLONGATION;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; BODY TEMPERATURE; CELL LINE; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; ETHER-A-GO-GO POTASSIUM CHANNELS; FEVER; HETEROZYGOTE; HUMANS; ION CHANNEL GATING; LONG QT SYNDROME; MALE; MUTATION, MISSENSE; PROTEIN TRANSPORT; ROMANO-WARD SYNDROME; TEMPERATURE; TRANSFECTION;

EID: 46749147992     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JC135337     Document Type: Article

References (35)

1. Roden, D.M. 2008. Clinical practice. Long QT syndrome. N. Engl. J. Med. 358:169-176.
2. January, C.T., Gong, Q., and Zhou, Z. 2000. Long QT syndrome: cellular basis and arrhythmia mechanism in LQT2. J. Cardiovasc. Electrophysiol. 11:1413-1418.
3. + channel dysfunction in an inherited cardiac arrhythmia. Proc. Natl. Acad. Sci. U. S. A. 93:2208-2212.
4. MacKinnon, R. 1991. Determination of the subunit stoichiometry of a voltage-activated potassium channel. Nature. 350:232-235.
5. Anderson, C.L., et al. 2006. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation. 113:365-373.
6. Ficker, E., et al. 2000. Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome. J. Mol. Cell. Cardiol. 32:2327-2337.
7. Delisle, B.P., Anson, B.D., Rajamani, S., and January, C.T. 2004. Biology of cardiac arrhythmias: ion channel protein trafficking. Circ. Res. 94:1418-1428.
8. Tan, H.L., Hou, C.J., Lauer, M.R., and Sung, R.J. 1995. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann. Intern. Med. 122:701-714.
9. Schwartz, P.J., et al. 2001. Genotype-phenotype correlation in the long QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 103:89-95.
10. Wilde, A.A., et al. 1999. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KvLQT1-related patients (LQTS1). J. Am. Coll. Cardiol. 33:327-332.
11. Mackowiak, P.A. 1998. Concepts of fever. Arch. Intern. Med. 158:1870-1881.
12. Jongbloed, R.J., et al. 1999. Novel KCNQ1 and HERG missense mutations in Dutch long QT families. Hum. Mutat. 13:301-310.
13. Tan, H.L., Alings, M., Van Olden, R.W., and Wilde, A.A. 1999. Long-term (subacute) potassium treatment in congenital HERG-related long QT syndrome (LQTS2). J. Cardiovasc. Electrophysiol. 10:229-233.
14. Gaita, F., et al. 2003. Short QT Syndrome: a familial cause of sudden death. Circulation. 108:965-970.
15. Kr. Am. J. Physiol. Heart Circ. Physiol. 290:H1278-H1288.
16. Zhou, Z., et al. 1998. Properties of HERG channels stably expressed in HEK-293 cells studied at physiological temperature. Biophys J. 74:230-241.
17. Ficker, E., Dennis, A.T., Wang, L., and Brown, A.M. 2003. Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG. Circ. Res. 92:E87-E100.
18. Kr and its trafficking disruption induced by probucol in cultured neonatal rat cardiomyocytes. J. Pharmacol. Exp. Ther. 321:911-920.
19. Tester, D.J., Will, M.L., Haglund, C.M., and Ackerman, M.J. 2005. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm. 2:507-517.
20. Antzelevitch, C., and Brugada, R. 2002. Fever and Brugada syndrome. Pacing Clin. Electrophysiol. 25:1537-1539.
21. Keller, D.I., et al. 2006. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation. Cardiovasc Res. 70:521-529.
22. Porres, J.M., et al. 2002. Fever unmasking the Brugada syndrome. Pacing Clin. Electrophysiol. 25:1646-1648.
23. Antzelevitch, C., et al. 2005. Brugada syndrome: report of the second consensus conference. Heart Rhythm. 2:429-440.
24. Dumaine, R., et al. 1999. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ. Res. 85:803-809.
25. + channel does not affect ion selectivity properties. Acta Physiol. Scand. 185:291-301.
26. Karjalainen, J., and Viitasalo, M. 1986. Fever and cardiac rhythm. Arch. Intern. Med. 146:1169-1171.
27. Morita, H., Zipes, D.P., Morita, S.T., and Wu, J. 2007. Temperature modulation of ventricular arrhythmogenicity in a canine tissue model of Brugada syndrome. Heart Rhythm. 2:188-197
28. + currents. Am. J. Physiol. Cell Physiol. 291:C165-C175.
29. Gong, Q., Anderson, C.L., January, C.T., and Zhou, Z. 2004. Pharmacological rescue of trafficking defective HERG channels formed by coassembly of wild-type and long QT mutant N470D subunits. Am. J. Physiol. Heart Circ. Physiol. 287:H652-H658.
30. Zeng, J., Laurita, K.R., Rosenbaum, D.S., and Rudy, Y. 1995. Two components of the delayed rectifier K+ current in ventricular myocytes of the guinea pig type. Theoretical formulation and their role in repolarization. Circ. Res. 77:140-152.
31. 2+ channels in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 282:H1092-H1101.
32. Burashnikov, A., and Antzelevitch, C. 1998. Temperature-dependence of early afterdepolarization activity in canine left ventricular M cell and Purkinje fiber preparations [abstract]. Pacing Clin. Electrophysiol. 21:II-857.
33. Yan, G.X., et al. 2001. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome: direct evidence from intracellular recordings in the intact left ventricular wall. Circulation. 103:2851-2856.
34. Yao, J.A., et al. 2005. Estimation of potency of HERG channel blockers: impact of voltage protocol and temperature. J. Pharmacol. Toxicol. Methods. 52:146-153.
35. Kirsch, G.E., et al. 2004. Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern. J. Pharmacol. Toxicol. Methods. 50:93-101.